Preventative Health Testing: Benefits, Limits and False Reassurance

Preventative testing can find some diseases before symptoms appear, sometimes at a stage when treatment is easier or more effective. But testing is not automatically beneficial simply because it finds more abnormalities. Every screening decision involves a balance between possible benefit, false alarms, missed disease, incidental findings, overdiagnosis and the consequences of whatever happens next. In Alberta, where adults can now pay for certain preventative imaging without a physician referral, understanding those trade-offs has become even more important.

What is preventative testing?

Preventative testing, often called screening, generally looks for disease or risk before a person develops symptoms.

That is different from diagnostic testing, which is usually performed because someone has symptoms, an abnormal examination, a previous abnormal result or another reason to suspect a particular condition.

Screening can be extremely valuable when there is good evidence that finding a particular disease earlier improves meaningful health outcomes.

But that does not mean screening everyone for everything produces better health.

The real goal is not simply finding more disease

A screening program should do more than discover abnormalities.

The important question is whether finding a condition earlier gives people a meaningful opportunity to avoid serious illness, disability or premature death.

For some diseases, evidence supports screening particular groups at particular ages or risk levels.

For others, routinely searching healthy people may produce little benefit or create additional harm.

This is why established screening programs have eligibility criteria rather than simply testing every person as often as possible.

Earlier detection can be valuable

One potential benefit of screening is finding disease before it has progressed.

In the right circumstances, earlier detection can allow earlier treatment and may improve outcomes.

This principle is central to established cancer screening programs.

But “earlier” and “better” are not automatically the same thing. The disease, the test and the available treatment all matter.

What is a false positive?

A false-positive result suggests that a disease or abnormality may be present when it is not actually there.

This does not necessarily mean someone was incorrectly told they definitely had a disease.

Often it means the first test produced a finding that requires additional investigation before it can be shown to be harmless.

Follow-up can involve repeat imaging, laboratory tests, specialist consultations or sometimes an invasive procedure such as a biopsy.

False positives can also create substantial anxiety while someone waits to learn what a finding means.

What is a false negative?

A false-negative result occurs when a test does not identify a disease or condition that is actually present.

No screening test detects every case.

This is one reason a normal test result should not be interpreted as a guarantee that you are healthy.

If you develop symptoms or have an important change in your health, seek appropriate medical assessment even if a previous screening test was normal.

What is false reassurance?

False reassurance is not limited to a technically false-negative result.

It can also occur when someone gives a normal screening result more meaning than it deserves.

For example, one normal scan does not rule out every cancer, cardiovascular condition or other disease.

Different tests look at different parts of the body and have different strengths and limitations.

A normal result should answer the question that the test was designed to investigate, not become a general certificate of good health.

What are incidental findings?

Modern imaging can reveal abnormalities unrelated to the reason the test was performed.

These are often called incidental findings.

Some incidental findings are important and lead to useful treatment.

Others are harmless variations that would never have affected the person’s health.

The difficulty is that an unexpected finding sometimes cannot immediately be classified as harmless.

That uncertainty can start a chain of additional testing.

What is overdiagnosis?

Overdiagnosis is different from a false positive.

In overdiagnosis, the abnormality or disease found by screening is real, but it would never have caused symptoms or harmed the person during their lifetime.

Because doctors cannot always know with certainty which detected disease will progress, some people may undergo monitoring or treatment for a condition that would never have become clinically important.

Overdiagnosis can therefore lead to overtreatment.

More sensitive technology can create a paradox

Better imaging technology can identify smaller and subtler abnormalities than older technology.

That can be enormously valuable.

It can also increase the number of findings that require interpretation.

A test that finds more abnormalities is not automatically a test that saves more lives.

What matters is whether detecting and acting on those additional findings improves outcomes enough to outweigh the potential harms.

Your underlying risk changes what a test result means

Testing is generally more informative when there is a reasonable chance that the condition being sought is actually present.

Age, symptoms, family history, genetics, smoking history, previous disease and other factors can substantially change someone’s underlying risk.

This is one reason screening recommendations often target particular populations.

The same test can have a different balance of benefits and harms in a high-risk person than in someone with very low risk.

Radiation exposure can matter

Not all medical imaging uses radiation.

Ultrasound and MRI do not use ionizing radiation.

X-rays and CT scans do.

For an individual medically appropriate examination, the expected benefit can greatly outweigh the radiation risk.

But unnecessary or repeated imaging can create exposure without a corresponding clinical benefit.

Ask whether the proposed test uses ionizing radiation and whether that matters in your circumstances.

MRI has limitations too

The absence of ionizing radiation does not make MRI an unlimited screening tool.

MRI can reveal incidental findings, may require contrast in some circumstances and is not appropriate for every patient or every medical question.

Some implanted devices, foreign bodies and other circumstances require specific safety assessment.

The appropriate test depends on what clinicians are trying to find, not simply which technology sounds most advanced.

A blood test can also create uncertainty

The same principles extend beyond medical imaging.

Laboratory results are normally interpreted in context.

A value outside a reference range does not automatically mean disease is present, and a value within a reference range does not always exclude disease.

Medications, pregnancy, food, fasting, stress and other factors can influence some results.

Ordering large numbers of tests in a healthy person increases the opportunity to find at least one result outside a reference range simply by chance.

Screening works best when there is a plan for what comes next

Before taking a test, ask what will happen with each possible result.

If the result is abnormal, is there an accepted confirmatory test?

If disease is confirmed, is there effective treatment?

If the result is uncertain, how will it be investigated?

If the test is normal but symptoms later appear, what should you do?

Testing without a sensible follow-up pathway can create information without necessarily creating better healthcare.

Alberta now allows certain self-referred preventative imaging

Since July 31, 2026, adults in Alberta can book certain patient-paid preventative MRI, CT, ultrasound and X-ray examinations at participating private diagnostic clinics without first obtaining a physician referral.

A regulated health professional at the clinic must still confirm that the test is appropriate and obtain informed consent.

Patients pay the full cost at the time of service.

This pathway is optional and does not replace publicly funded medically necessary diagnostic testing.

What happens if self-referred testing finds cancer?

Under Alberta’s current rules, an eligible AHCIP patient may apply for reimbursement up to the established reimbursement rate if qualifying preventative imaging leads to a new cancer diagnosis.

Conditions apply, including requirements relating to the date of testing, clinic accreditation and the timing of the reimbursement application.

If no cancer is diagnosed, the patient-paid test is not reimbursed through this program.

A patient whose testing detects cancer is referred into the publicly funded healthcare system for appropriate follow-up care.

Public cancer screening programs still exist

Alberta’s established publicly funded cancer screening programs have not been replaced by the new patient-pay pathway.

Organized screening programs are designed around evidence about who is most likely to benefit, which test should be used and how frequently screening should occur.

If you are eligible for an established screening program, it is worth understanding that pathway before purchasing additional testing.

Be cautious with the phrase “peace of mind”

Private preventative testing is sometimes marketed as providing peace of mind.

A useful test may certainly provide reassurance.

But reassurance should match what the test can actually establish.

A normal CT scan, MRI, ultrasound, blood panel or other test cannot prove that nothing is wrong anywhere in the body.

Conversely, an unexpected finding can create considerable uncertainty rather than reassurance.

Ask what question the test is capable of answering before deciding how much reassurance a normal result should provide.

Be cautious with packages containing many tests

A long list of tests can look more comprehensive than a focused medical assessment.

More tests create more data, but more data does not automatically mean better decision-making.

Before purchasing a screening package, ask why each test is included and whether it is recommended for someone with your age, history and risk profile.

Also ask what evidence shows that screening people like you improves outcomes.

Questions to ask before preventative testing

• What disease or condition is this test looking for?
• Am I at increased risk for that condition?
• Is screening recommended for someone like me?
• How accurate is the test?
• What are the chances of a false positive or false negative?
• Could it find incidental abnormalities?
• Is overdiagnosis a concern?
• Does the test involve radiation or contrast?
• What happens if the result is abnormal?
• What happens if the result is uncertain?
• What happens if the result is normal but I later develop symptoms?
• Is there an established publicly funded screening program?
• Will the result actually change what I do about my health?

Preventative healthcare is bigger than testing

Health screening is only one part of prevention.

Vaccination, blood pressure management, appropriate cancer screening, tobacco avoidance, physical activity, nutrition, sleep, medication management and addressing known health risks can all matter.

It is possible to spend heavily on sophisticated testing while overlooking simpler preventive measures with stronger evidence.

The most technologically impressive option is not necessarily the most valuable one.

The PureFarmFresh approach

Preventative testing can be useful, and greater access gives Albertans more choices.

But the purpose of testing should be better health decisions, not simply accumulating more scans, numbers and reports.

Before testing, understand what is being looked for, how likely you are to benefit, what the test can miss and what happens if it finds something unexpected.

A good screening decision considers the possibility of finding disease and the consequences of looking for it.

We explain the system. You decide what matters to you.